Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05660512 · ClinicalTrials.gov registry record
Intracept Intraosseous Basivertebral Nerve Ablation
A clinical trial of Low Back Pain, sponsored by University of Utah.
- Active
- Registry status
- 150
- Enrollment target
- 3
- Study locations
NCT05660512: Active study of Low Back Pain, sponsored by University of Utah.
NCT05660512 is a study of Low Back Pain that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 150 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (70% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05660512, a study of Low Back Pain, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is an independent prospective, noninterventional, observational post-market data collection of the patient-reported effectiveness, ongoing safety and satisfaction outcomes for patients treated with the Intracept Procedure at a single study site.
Primary Outcome
Validated questionnaire of low back pain related disability. Comprised of 10 questions evaluating the impact of low back pain on activities of daily living. The ODI is scored on a scale of 0 (no disability) to 100 (complete disability), with categories of 0-20 (minimal disability), 21-40 (moderate disability), 41-60 (severe disability), 61-80 (crippling back pain), and 81-100 (bed-bound or exaggerating). Comparison of mean ODI baseline to 3 months.
Conditions Studied
Interventions
- PROCEDURE Intracept Procedure
Study Locations (3)
Utah
- University of Utah Farmington Health Center - Farmington
- University of Utah Orthopaedic Center - Salt Lake City
- University of Utah South Jordan Health Center - South Jordan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2026-07 |
What the registry record for NCT05660512 still lists
NCT05660512 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Intracept Procedure is the first listed.
NCT05660512 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05660512 about?
NCT05660512 is a clinical study titled "Intracept Intraosseous Basivertebral Nerve Ablation". This is an independent prospective, noninterventional, observational post-market data collection of the patient-reported effectiveness, ongoing safety and satisfaction outcomes for patients treated with the Intracept Procedure at a single study site.
What is the current status of trial NCT05660512?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2020-07-27. Estimated completion is 2026-07.
What conditions does trial NCT05660512 study?
This clinical trial studies the following conditions: Low Back Pain.
What interventions are being tested in trial NCT05660512?
The interventions under investigation include: Intracept Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT05660512?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05660512 being conducted?
This trial has 3 study locations across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05660512's enrollment target sits among peer trials
150 43rd of 122 higher than 79 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Opioid Response to Injections
RECRUITING · Phase 4
-
Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
RECRUITING · NA
-
Evaluation of the Effects of a Rehabilitation Program in Individuals with Spine Pain
RECRUITING
-
The Spine Phenome Project
RECRUITING
-
Overlapping Pain Trajectory Study
RECRUITING
-
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI